Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: Results from the CORRONA registry and meta-analysis

Inflammation

Volumn 36, Issue 2, 2013, Pages 279-284

  Pappas, Dimitrios A ^a   Oh, Cheongeun ^b   Plenge, Robert M ^c   Kremer, Joel M ^d   Greenberg, Jeffrey D ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

pharmacogenetics; rheumatoid arthritis; TNF alpha inhibitors

Indexed keywords

CD28 ANTIGEN; METHOTREXATE; RHEUMATOID FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CCL21 GENE; CD28 GENE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DRUG RESPONSE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD28; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHEMOKINE CCL21; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879502298     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9544-4     Document Type: Article

References (13)

1. Kievit, W.; E.M. Adang, J. Fransen, H.H. Kuper, M.A. van de Laar, T.L. Jansen, C.M. De Gendt, D.J. De Rooij, H.L. Brus, P.C. Van Oijen, and P.C. Van Riel. 2008. The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Annals of the Rheumatic Diseases 67: 1229-1234.
2. Cui, J.; S. Saevarsdottir, B. Thomson, L. Padyukov, A.H. van der Helm-van Mil, J. Nititham, L.B. Hughes, N. de Vries, S. Raychaudhuri, L. Alfredsson, J. Askling, S. Wedrén, B. Ding, C. Guiducci, G.J. Wolbink, J.B. Crusius, I.E. van der Horst-Bruinsma, M. Herenius, M.E. Weinblatt, N.A. Shadick, J. Worthington, F. Batliwalla, M. Kern, A.W. Morgan, A.G. Wilson, J.D. Isaacs, K. Hyrich, M.F. Seldin, L.W. Moreland, T.W. Behrens, C.F. Allaart, L.A. Criswell, T.W. Huizinga, P.P. Tak, S.L. Bridges Jr.; R.E. Toes, A. Barton, L. Klareskog, P.K. Gregersen, E.W. Karlson, and R.M. Plenge. 2010. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis and Rheumatism 62: 1849-1861.
3. Kremer, J.M. 2006. The CORRONA database. Autoimmun Reviews 5: 46-54.
4. Stahl, E.A.; S. Raychaudhuri, E.F. Remmers, G. Xie, S. Eyre, B.P. Thomson, Y. Li, F.A. Kurreeman, A. Zhernakova, A. Hinks, C. Guiducci, R. Chen, L. Alfredsson, C.I. Amos, K.G. Ardlie, BIRAC Consortium, A. Barton, J. Bowes, E. Brouwer, N.P. Burtt, J.J. Catanese, J. Coblyn, M.J. Coenen, K.H. Costenbader, L.A. Criswell, J.B. Crusius, J. Cui, P.I. de Bakker, P.L. De Jager, B. Ding, P. Emery, E. Flynn, P. Harrison, L.J. Hocking, T.W. Huizinga, D.L. Kastner, X. Ke, A.T. Lee, X. Liu, P. Martin, A.W. Morgan, L. Padyukov, M.D. Posthumus, T.R. Radstake, D.M. Reid, M. Seielstad, M.F. Seldin, N.A. Shadick, S. Steer, P.P. Tak, W. Thomson, A.H. van der Helm-van Mil, I.E. van der Horst-Bruinsma, C.E. van der Schoot, P.L. van Riel, M.E. Weinblatt, A.G. Wilson, G.J. Wolbink, B.P. Wordsworth, YEAR Consortium, C. Wijmenga, E.W. Karlson, R.E. Toes, N. de Vries, A.B. Begovich, J. Worthington, K.A. Siminovitch, P.K. Gregersen, L. Klareskog, and R.M. Plenge. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics 42: 508-514.
5. Raychaudhuri, S.; E.F. Remmers, A.T. Lee, R. Hackett, C. Guiducci, N.P. Burtt, L. Gianniny, B.D. Korman, L. Padyukov, F.A. Kurreeman, M. Chang, J.J. Catanese, B. Ding, S. Wong, A.H. van der Helm-van Mil, B.M. Neale, J. Coblyn, J. Cui, P.P. Tak, G.J. Wolbink, J.B. Crusius, I.E. van der Horst-Bruinsma, L.A. Criswell, C.I. Amos, M.F. Seldin, D.L. Kastner, K.G. Ardlie, L. Alfredsson, K.H. Costenbader, D. Altshuler, T.W. Huizinga, N.A. Shadick, M.E. Weinblatt, N. de Vries, J. Worthington, M. Seielstad, R.E. Toes, E.W. Karlson, A.B. Begovich, L. Klareskog, P.K. Gregersen, M.J. Daly, and R.M. Plenge. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nature Genetics 40: 1216-1223.
6. Bentley, M.J.; J.D. Greenberg, and G.W. Reed. 2010. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research. Journal of Rheumatology 37: 1607-1614.
7. Green GH and Diggle PJ. On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure. Stat Appl Genet Mol Biol 2007;6:Article27.
8. Normand, S.L. 1999. Meta-analysis: Formulating, evaluating, combining, and reporting. Statistics in Medicine 18: 321-359.
9. Klareskog, L.; A.I. Catrina, and S. Paget. 2009. Rheumatoid arthritis. Lancet 373: 659-672.
10. Plenge, R.M. 2009. Recent progress in rheumatoid arthritis genetics: One step towards improved patient care. Current Opinion in Rheumatology 21: 262-271.
11. Potter, C.; K.L. Hyrich, A. Tracey, M. Lunt, D. Plant, D.P. Symmons, W. Thomson, J. Worthington, P. Emery, A.W. Morgan, A.G. Wilson, J. Isaacs, A. Barton, and and the BRAGGSS. 2009. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Annals of the Rheumatic Diseases 68: 69-74.
12. Tan, R.J.; L.J. Gibbons, C. Potter, K.L. Hyrich, A.W. Morgan, A.G. Wilson, J.D. Isaacs, BRAGGSS, and A. Barton. 2010. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment. Annals of the Rheumatic Diseases 69: 1029-1035.
13. Purcell, S.; S.S. Cherny, and P.C. Sham. 2003. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1): 149-150.